2dxs
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2dxs.jpg|left|200px]] | [[Image:2dxs.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2dxs", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_2dxs| PDB=2dxs | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''Crystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitor''' | '''Crystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitor''' | ||
Line 36: | Line 33: | ||
[[Category: Uehara, K.]] | [[Category: Uehara, K.]] | ||
[[Category: Watanabe, S.]] | [[Category: Watanabe, S.]] | ||
- | [[Category: | + | [[Category: Hcv]] |
- | [[Category: | + | [[Category: Ns5b]] |
- | [[Category: | + | [[Category: Rna polymerase]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 01:35:01 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 22:35, 3 May 2008
Crystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitor
Overview
We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H-benzo[5,6][1,4]diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.
About this Structure
2DXS is a Single protein structure of sequence from Hepatitis c virus. Full crystallographic information is available from OCA.
Reference
Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors., Ikegashira K, Oka T, Hirashima S, Noji S, Yamanaka H, Hara Y, Adachi T, Tsuruha J, Doi S, Hase Y, Noguchi T, Ando I, Ogura N, Ikeda S, Hashimoto H, J Med Chem. 2006 Nov 30;49(24):6950-3. PMID:17125247 Page seeded by OCA on Sun May 4 01:35:01 2008